Financials data is unavailable for this security.
View more
Year on year Noxopharm Ltd had revenues fall -60.33% from 6.07m to 2.41m, though the company grew net income from a loss of 15.06m to a smaller loss of 3.58m.
| Gross margin | -- |
|---|---|
| Net profit margin | -148.64% |
| Operating margin | -190.87% |
| Return on assets | -42.31% |
|---|---|
| Return on equity | -49.12% |
| Return on investment | -48.67% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Noxopharm Ltd fell by 688.74k. However, Cash Flow from Investing was flat, indicating that little new money was committed to growth. In addition the company used 684.31k for operations while cash from financing was breakeven.
| Cash flow per share | -0.0122 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.0188 |
|---|---|
| Tangible book value per share | 0.0188 |
More ▼
Balance sheet in AUDView more
| Current ratio | 3.83 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
